Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer (Q40515050)

21 September 2017

Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer (English)

1 reference

21 September 2017

1 reference

Yang WQ

1

1 reference

21 September 2017

Senger DL

2

1 reference

21 September 2017

Lun XQ

3

1 reference

21 September 2017

Muzik H

4

1 reference

21 September 2017

Shi ZQ

5

1 reference

21 September 2017

Dyck RH

6

1 reference

21 September 2017

Norman K

7

1 reference

21 September 2017

Brasher PM

8

1 reference

21 September 2017

Rewcastle NB

9

1 reference

21 September 2017

George D

10

1 reference

21 September 2017

Stewart D

11

1 reference

21 September 2017

Lee PW

12

1 reference

21 September 2017

Forsyth PA

13

1 reference

21 September 2017

1 November 2004

1 reference

21 September 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Gene Therapy

1 reference

21 September 2017

11

1 reference

21 September 2017

21

1 reference

21 September 2017

1579-1589

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302319

21 September 2017

0 references

cites work

Central nervous system metastasis from breast carcinoma. Autopsy study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Patterns of metastasis and natural courses of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Brain metastases in breast cancer; natural history, prognostic factors and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

The alpha-anomeric form of sialic acid is the minimal receptor determinant recognized by reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Junction adhesion molecule is a receptor for reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus oncolysis of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus as an oncolytic agent against experimental human malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus therapy of lymphoid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Quantitative effects of cerebral infarction on spatial learning in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Comparisons between C57BL/6J and A/J mice in motor activity and coordination, hole-poking, and spatial learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Place navigation impaired in rats with hippocampal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

An experimental model of leptomeningeal metastases employing rat mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Humanization of an anti-p185HER2 antibody for human cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus-induced apoptosis is mediated by TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

Reovirus binds to multiple plasma membrane proteins of mouse L fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302319

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302319

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference